1. Home
  2. WIMI vs ITRM Comparison

WIMI vs ITRM Comparison

Compare WIMI & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WIMI
  • ITRM
  • Stock Information
  • Founded
  • WIMI 2015
  • ITRM 2015
  • Country
  • WIMI China
  • ITRM Ireland
  • Employees
  • WIMI N/A
  • ITRM N/A
  • Industry
  • WIMI Computer Software: Prepackaged Software
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • WIMI Technology
  • ITRM Health Care
  • Exchange
  • WIMI Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • WIMI 38.3M
  • ITRM 40.0M
  • IPO Year
  • WIMI 2020
  • ITRM 2018
  • Fundamental
  • Price
  • WIMI $4.67
  • ITRM $0.77
  • Analyst Decision
  • WIMI
  • ITRM Strong Buy
  • Analyst Count
  • WIMI 0
  • ITRM 1
  • Target Price
  • WIMI N/A
  • ITRM $9.00
  • AVG Volume (30 Days)
  • WIMI 508.0K
  • ITRM 739.9K
  • Earning Date
  • WIMI 01-01-0001
  • ITRM 11-13-2025
  • Dividend Yield
  • WIMI N/A
  • ITRM N/A
  • EPS Growth
  • WIMI N/A
  • ITRM N/A
  • EPS
  • WIMI 1.43
  • ITRM N/A
  • Revenue
  • WIMI $61,329,146.00
  • ITRM N/A
  • Revenue This Year
  • WIMI N/A
  • ITRM N/A
  • Revenue Next Year
  • WIMI N/A
  • ITRM $482.25
  • P/E Ratio
  • WIMI $3.43
  • ITRM N/A
  • Revenue Growth
  • WIMI N/A
  • ITRM N/A
  • 52 Week Low
  • WIMI $2.24
  • ITRM $0.61
  • 52 Week High
  • WIMI $29.20
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • WIMI 56.96
  • ITRM 59.02
  • Support Level
  • WIMI $4.61
  • ITRM $0.66
  • Resistance Level
  • WIMI $5.04
  • ITRM $0.81
  • Average True Range (ATR)
  • WIMI 0.47
  • ITRM 0.05
  • MACD
  • WIMI -0.02
  • ITRM 0.01
  • Stochastic Oscillator
  • WIMI 28.36
  • ITRM 63.76

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: